403 related articles for article (PubMed ID: 20605919)
41. Farnesyltransferase inhibitor and rapamycin correct aberrant genome organisation and decrease DNA damage respectively, in Hutchinson-Gilford progeria syndrome fibroblasts.
Bikkul MU; Clements CS; Godwin LS; Goldberg MW; Kill IR; Bridger JM
Biogerontology; 2018 Dec; 19(6):579-602. PubMed ID: 29907918
[TBL] [Abstract][Full Text] [Related]
42. Status of treatment strategies for Hutchinson-Gilford progeria syndrome with a focus on prelamin: A posttranslational modification.
Chen X; Yao H; Andrés V; Bergo MO; Kashif M
Basic Clin Pharmacol Toxicol; 2022 Oct; 131(4):217-223. PubMed ID: 35790078
[TBL] [Abstract][Full Text] [Related]
43. Neuropeptide Y Enhances Progerin Clearance and Ameliorates the Senescent Phenotype of Human Hutchinson-Gilford Progeria Syndrome Cells.
Aveleira CA; Ferreira-Marques M; Cortes L; Valero J; Pereira D; Pereira de Almeida L; Cavadas C
J Gerontol A Biol Sci Med Sci; 2020 May; 75(6):1073-1078. PubMed ID: 32012215
[TBL] [Abstract][Full Text] [Related]
44. Lamin A, farnesylation and aging.
Reddy S; Comai L
Exp Cell Res; 2012 Jan; 318(1):1-7. PubMed ID: 21871450
[TBL] [Abstract][Full Text] [Related]
45. Investigation of age-related changes in LMNA splicing and expression of progerin in human skeletal muscles.
Luo YB; Mitrpant C; Johnsen RD; Fabian VA; Fletcher S; Mastaglia FL; Wilton SD
Int J Clin Exp Pathol; 2013; 6(12):2778-86. PubMed ID: 24294364
[TBL] [Abstract][Full Text] [Related]
46. Effect of progerin on the accumulation of oxidized proteins in fibroblasts from Hutchinson Gilford progeria patients.
Viteri G; Chung YW; Stadtman ER
Mech Ageing Dev; 2010 Jan; 131(1):2-8. PubMed ID: 19958786
[TBL] [Abstract][Full Text] [Related]
47. Enhanced nuclear protein export in premature aging and rescue of the progeria phenotype by modulation of CRM1 activity.
García-Aguirre I; Alamillo-Iniesta A; Rodríguez-Pérez R; Vélez-Aguilera G; Amaro-Encarnación E; Jiménez-Gutiérrez E; Vásquez-Limeta A; Samuel Laredo-Cisneros M; Morales-Lázaro SL; Tiburcio-Félix R; Ortega A; Magaña JJ; Winder SJ; Cisneros B
Aging Cell; 2019 Oct; 18(5):e13002. PubMed ID: 31305018
[TBL] [Abstract][Full Text] [Related]
48. Targeting the phospholipase A2 receptor ameliorates premature aging phenotypes.
Griveau A; Wiel C; Le Calvé B; Ziegler DV; Djebali S; Warnier M; Martin N; Marvel J; Vindrieux D; Bergo MO; Bernard D
Aging Cell; 2018 Dec; 17(6):e12835. PubMed ID: 30216637
[TBL] [Abstract][Full Text] [Related]
49. Lysophosphatidic acid receptor LPA
Chen WM; Chiang JC; Lin YC; Lin YN; Chuang PY; Chang YC; Chen CC; Wu KY; Hsieh JC; Chen SK; Huang WP; Chen BPC; Lee H
Aging Cell; 2020 Jan; 19(1):e13064. PubMed ID: 31714004
[TBL] [Abstract][Full Text] [Related]
50. Permanent farnesylation of lamin A mutants linked to progeria impairs its phosphorylation at serine 22 during interphase.
Moiseeva O; Lopes-Paciencia S; Huot G; Lessard F; Ferbeyre G
Aging (Albany NY); 2016 Feb; 8(2):366-81. PubMed ID: 26922519
[TBL] [Abstract][Full Text] [Related]
51. [Progerin and Its Role in Accelerated and Natural Aging].
Mosevitsky MI
Mol Biol (Mosk); 2022; 56(2):181-205. PubMed ID: 35403615
[TBL] [Abstract][Full Text] [Related]
52. Progerin Expression Induces Inflammation, Oxidative Stress and Senescence in Human Coronary Endothelial Cells.
Bidault G; Garcia M; Capeau J; Morichon R; Vigouroux C; Béréziat V
Cells; 2020 May; 9(5):. PubMed ID: 32408587
[TBL] [Abstract][Full Text] [Related]
53. Progerin impairs 3D genome organization and induces fragile telomeres by limiting the dNTP pools.
Kychygina A; Dall'Osto M; Allen JAM; Cadoret JC; Piras V; Pickett HA; Crabbe L
Sci Rep; 2021 Jun; 11(1):13195. PubMed ID: 34162976
[TBL] [Abstract][Full Text] [Related]
54. Presence and distribution of progerin in HGPS cells is ameliorated by drugs that impact on the mevalonate and mTOR pathways.
Clements CS; Bikkul MU; Ofosu W; Eskiw C; Tree D; Makarov E; Kill IR; Bridger JM
Biogerontology; 2019 Jun; 20(3):337-358. PubMed ID: 31041622
[TBL] [Abstract][Full Text] [Related]
55. Nuclear Pore Complexes Cluster in Dysmorphic Nuclei of Normal and Progeria Cells during Replicative Senescence.
Röhrl JM; Arnold R; Djabali K
Cells; 2021 Jan; 10(1):. PubMed ID: 33466669
[TBL] [Abstract][Full Text] [Related]
56. Telomere elongation through hTERT immortalization leads to chromosome repositioning in control cells and genomic instability in Hutchinson-Gilford progeria syndrome fibroblasts, expressing a novel SUN1 isoform.
Bikkul MU; Faragher RGA; Worthington G; Meinke P; Kerr ARW; Sammy A; Riyahi K; Horton D; Schirmer EC; Hubank M; Kill IR; Anderson RM; Slijepcevic P; Makarov E; Bridger JM
Genes Chromosomes Cancer; 2019 Jun; 58(6):341-356. PubMed ID: 30474255
[TBL] [Abstract][Full Text] [Related]
57. Lamin A and telomere maintenance in aging: Two to Tango.
Sengupta D; Sengupta K
Mutat Res; 2022; 825():111788. PubMed ID: 35687934
[TBL] [Abstract][Full Text] [Related]
58. The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin.
McClintock D; Ratner D; Lokuge M; Owens DM; Gordon LB; Collins FS; Djabali K
PLoS One; 2007 Dec; 2(12):e1269. PubMed ID: 18060063
[TBL] [Abstract][Full Text] [Related]
59. Inhibiting farnesylation of progerin prevents the characteristic nuclear blebbing of Hutchinson-Gilford progeria syndrome.
Capell BC; Erdos MR; Madigan JP; Fiordalisi JJ; Varga R; Conneely KN; Gordon LB; Der CJ; Cox AD; Collins FS
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12879-84. PubMed ID: 16129833
[TBL] [Abstract][Full Text] [Related]
60. Longwave UV light induces the aging-associated progerin.
Takeuchi H; Rünger TM
J Invest Dermatol; 2013 Jul; 133(7):1857-62. PubMed ID: 23392295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
